Chi-Yi Chen

cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18–Infected Lung Cancer

Heng-Hsiung Wu, Jeng-Yuan Wu, Ya‐Wen Cheng et al. · Clinical Cancer Research · 2010 · 74 citations · Full text

Medicine, Cancer Biology, Oncology +17

Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2

Min‐Che Tung, Po-Lin Lin, Ya‐Wen Cheng et al. · Oncotarget · 2016 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +15

Cytoplasmic Ape1 Expression Elevated by p53 Aberration May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer

Heng-Hsiung Wu, Ya-Chiung Chu, Lee Wang et al. · Annals of Surgical Oncology · 2012 · 37 citations

Medicine, Molecular Genetics, Oncology +13

PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Ming-Jenn Chen, De‐Wei Wu, Yao-Chen Wang et al. · Scientific Reports · 2016 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +17

MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2

Ming-Jenn Chen, De‐Wei Wu, Gao-Chang Wang et al. · Oncotarget · 2018 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17